KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-210.31M
↓ 155% vs avg
Percentile
P0
Near historical low
Streak
8 yr
Consecutive declineContracting
Average
$-82.62M
Historical baseline
PeriodValueYoY Change
TTM$-210.31M-14.6%
2025$-183.44M-44.9%
2024$-126.64M-36.3%
2023$-92.91M-12.8%
2022$-82.34M-78.1%
2021$-46.24M-58.8%
2020$-29.12M-39.9%
2019$-20.82M-31.7%
2018$-15.80M+15.0%
2017$-18.60M-